Neudle.com: multiple sclerosis secondary progressive

Differential
(Click to cross reference)

accelerometry

acquired immunodeficiency syndrome

adverse drug reaction

alkylating agents

amphiphysin antibodies

autonomic dysfunction

autonomic neuropathy

azathioprine

B cell lymphocytes

Barkhof MR criteria for MS

bone marrow suppression

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebral cortex

cerebral cortical atrophy

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident, secondary prevention

cladribine

clemastine fumarate

clinicoradiologic dissociation

collapsin response mediator protein 5 IgG

complications

contactin associated protein like 2 antibodies

controversies in neurology

digital health, wearable technology

disability rating scale, neurological

disability, neurological

disease modifying agents

efficacy

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

epidemiology of neurology

gammaglobulin therapy, intravenous

ganglionitis

gray matter

herpes virus infection

highly active antiretroviral therapy

human immunodeficiency virus type 1

hypertension

immune reconstitution inflammatory syndrome

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

leucine rich glioma inactivated 1 antibodies

middle cerebellar peduncle

middle cerebellar peduncle, lesion

misdiagnosis

mitoxantrone

monoclonal antibodies

mononeuritis multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelopathy

myelopathy, necrotizing

natalizumab

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, peripheral

NMDA antagonists

ocrelizumab

onconeural antibodies

opsoclonus-myoclonus syndrome

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

peripheral nerve, lesion of

placebo

plasmapheresis

pleocytosis of cerebrospinal fluid

practice guidelines

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

psychological testing

quality of life

ReBUILD study

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

Sjogren's syndrome, neurologic manifestations of

steroid

steroid therapy, CNS treatment and complications with

thrombocytopenia

treatment of neurologic disorder

tumor necrosis factor

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

wheelchair

white matter disease

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 1250 to 1300 of 6278 << Previous Next >>

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

An Analysis of Extended Survival in Patients with Amyotrophic Lateral Sclerosis Treated with Riluzole
Arch Neurol 55:526-528, Riviere,M.,et al, 1998

Magnetic Resonance Imaging of Muscle in Amyotrophic Lateral Sclerosis
Neurol 51:110-113, Bryan,W.W.,et al, 1998

MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease:Significance of Perihippocampal Fissures
AJNR 19:813-819, Holodny,A.I.,et al, 1998

CSF Spaces in Idiopathic Normal Pressure Hydrocephalus:Morphology and Volumetry
AJNR 19:1277-1284, 12851998., Kitagaki,H.,et al, 1998

Magnetization Transfer Changes in Normal Appearing White Matter Precede Appear of Enhancing Lesions in Pts with MS
Ann Neurol 43:809-814, Filippi,M.,et al, 1998

Correlation of Perfusion-and Diffusion-Weighted MRI with NIHSS Score in Acute (<6. 5 hr) Ischemic Stroke
Neurol 50:864-870, 8421998., Tong,D.C.,et al, 1998

Prediction of Stroke Outcome with Echoplanar Perfusion-and Diffusion-Weighted MRI
Neurol 51:418-426, Barber,P.A.,et al, 1998

Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998

Cerebellum in Attention-Deficit Hyperactivity Disorder
Neurol 50:1087-1093, Berquin,P.C.,et al, 1998

Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998

The Predictive Value of CSF Ologoclonal Banding for MS 5 Years After Optic Neuritis
Neurol 51:885-887, Cole,S.R.,et al, 1998

Clinicopath Conf,Syndrome of Mitochondrial Encephalopathy,Lactic Acidosis,and Stroke-Like Episodes (MELAS),Case 39-1998
NEJM 339:1914-1923, , 1998

Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers Toward Assisted Suicide
NEJM 339:967-973,987, Ganzini,L.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998

Subdural Haemorrhages in Infants:Population Based Study
BMJ 317:1558-1561,1538, Jayawant,S.,et al, 1998

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998

Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
Stroke 29:798-804, Hopp,J.W.,et al, 1998

Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998

Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998

Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998

Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998

Transverse Myelitis, Comparison with Spinal Cord Presentations of Multiple Sclerosis
Neurol 50:429-433, Scott,T.F.,et al, 1998

Migraine and Reduced Work Performance, A Population-Based Diary Study
Neurol 50:1741-1745, Von Korff,M.,et al, 1998

Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998

A 35-Year-Old Bricklayer with Hemimyoclonic Jerks
Lancet 351:1926, Grunewald,T.,et al, 1998

Amyloid Neuropathy Simulating Lower Motor Neuron Disease
Neurol 51:600-602, Quattrini,A.,et al, 1998

Craniocerebral Magnetic Resonance Imaging Measurement and Findings in Lesch-Nyhan Syndrome
Arch Neurol 55:547-553, Harris,J.C.,et al, 1998

Near-Fatal Heat Stroke During the 1995 Heat Wave in Chicago
Ann Int Med 129:173-181, Damatte,J.E.,et al, 1998

Incidence and Significance of Neutralizing Antibodies to Interferon Beta-1a in Multiple Sclerosis
Neurol 50:1266-1272, 12061998., Rudick,R.A.,et al, 1998

Mechanisms of Second and Further Strokes
JNNP 64:771-776, 7161998., Yamamoto,H.&Bogousslavsky,J., 1998

An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998

Gabapentin Relieves Trigeminal Neuralgia in Multiple Sclerosis Patients
Neurol 51:611-614, Khan,O.A., 1998

Rate of Pregnancy-Related Relapse in Multiple Sclerosis
NEJM 339:285-291, 3391998., Confavreux,C.,et al, 1998

Spinal Cord Atrophy and Disability in MS
Neurol 51:234-238, Stevenson,V.L.,et al, 1998

Synergistic Immunomod Effects of Interferon-Beta1b & Phosphodiesterase Inhib Pentoxifylline in Pts with Relapsing-Remit MS
Ann Neurol 44:27-34, 71998., Weber,F.,et al, 1998

Effects of Copolymer-1 on Serial Gadolinium-Enhanced MRI in Relapsing Remitting Multiple Sclerosis
Neurol 50:1127-1133, Mancardi,G.L.,et al, 1998

Intravenous Immunoglobulin G Reduces MRI Activity in Relapsing Multiple Sclerosis
Neurol 50:1273-1281, Sorensen,P.S.,et al, 1998

Double-Blind, Randomized, Placebo-Controlled Study of Oral, High-Dose Methylprednisolone in Attacks of MS
Neurol 51:529-534, Sellebjerg,F.,et al, 1998

Randomized Trial Comparing Two Different High Doses of Methylprednisolone in MS, A Clinical and MRI Study
Neurol 50:1833-1836, Oliveri,R.L.,et al, 1998

Multiple Sclerosis Associated with Chlamydia Pneumoniae Infection of the CNS
Neurol 50:571-572, Sriram,S.,et al, 1998

MR Findings of Werdnig-Hoffmann Disease in Two Infants
AJNR 19:550-552, Hsu,C.,et al, 1998

Distal Hereditary Upper Limb Muscular Atrophy
JNNP 64:217-220, Gross,D.W.,et al, 1998

Estimation of Brainstem Neuronal Loss in ALS with in Vivo Proton Magnetic Resonance Spectroscopy
Neurol 50:72-77, Cwik,V.A.,et al, 1998

Risk of Amyotrophic Lateral Sclerosis & History of Physical Activity, A Population Study
Arch Neurol 55:201-206, Longstreth,W.T.,et al, 1998

Toward Earlier Diagnosis of Amyotrophic Lateral Sclerosis, Revised Criteria
Neurol 50:768-772, Ross,M.A.,et al, 1998

Asympt Spinal Cord Lesions in Clin Isolated Optic Nerve, Brain Stem, & Spinal Cord Synd Suggest of Demyel
JNNP 64:353-357, O'Riordan,J.J.,et al, 1998

Effect of Steroids on Gd-Enhancing Lesions Before & During Beta Interferon 1a Trtm in Relapsing Remitting MS
Neurol 50:403-406, Gasperini,C.,et al, 1998

Showing articles 1250 to 1300 of 6278 << Previous Next >>